Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells

被引：59
|
作者：
Efimenko, Anastasia Yu. [1 ]
Kochegura, Tatiana N. [1 ]
Akopyan, Zhanna A. [1 ]
Parfyonova, Yelena V. [1 ,2 ]
机构：
[1] Moscow MV Lomonosov State Univ, Fac Med, Dept Biochem & Mol Med, Moscow 119192, Russia
[2] Russian Cardiol Res & Prod Complex, Lab Angiogenesis, Moscow, Russia
来源：
BIORESEARCH OPEN ACCESS | 2015年 / 4卷 / 01期
关键词：
D O I：
10.1089/biores.2014.0042
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
During recent years different types of adult stem/progenitor cells have been successfully applied for the treatment of many pathologies, including cardiovascular diseases. The regenerative potential of these cells is considered to be due to their high proliferation and differentiation capacities, paracrine activity, and immunologic privilege. However, therapeutic efficacy of the autologous stem/progenitor cells for most clinical applications remains modest, possibly because of the attenuation of their regenerative potential in aged patients with chronic diseases such as cardiovascular diseases and metabolic disorders. In this review we will discuss the risk factors affecting the therapeutic potential of adult stem/progenitor cells as well as the main approaches to mitigating them using the methods of regenerative medicine.
引用
收藏
页码：26 / 38
页数：13
相关论文
共 50 条
  • [21] Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases
    Tyndall, Alan
    Leblanc, Kararina
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (04): : 521 - 525
  • [22] Intestinal stem cells and stem cell-based therapy for intestinal diseases
    Mohamed, Mahmoud Shaaban
    Chen, Yun
    Yao, Chao-Ling
    CYTOTECHNOLOGY, 2015, 67 (02) : 177 - 189
  • [23] Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases
    Lanthier, Nicolas
    Rubbia-Brandt, Laura
    Spahr, Laurent
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (01): : 3 - 9
  • [24] Mobilization of stem and progenitor cells in cardiovascular diseases
    W Wojakowski
    U Landmesser
    R Bachowski
    T Jadczyk
    M Tendera
    Leukemia, 2012, 26 : 23 - 33
  • [25] Mobilization of stem and progenitor cells in cardiovascular diseases
    Wojakowski, W.
    Landmesser, U.
    Bachowski, R.
    Jadczyk, T.
    Tendera, M.
    LEUKEMIA, 2012, 26 (01) : 23 - 33
  • [26] Autologous stem cell transplantation in autoimmune diseases
    Passweg, Jakob
    Tyndall, Alan
    SEMINARS IN HEMATOLOGY, 2007, 44 (04) : 278 - 285
  • [27] Autologous Intravenous Mononuclear Stem Cell Therapy in Chronic Ischemic Stroke
    Bhasin, A.
    Srivastava, M., V
    Bhatia, R.
    Mohanty, S.
    Kumaran, S. S.
    Bose, S.
    JOURNAL OF STEM CELLS & REGENERATIVE MEDICINE, 2012, 8 (03): : P181 - P189
  • [28] Stem cell therapy for chronic lung diseases: Hope and reality
    Agostini, Carlo
    RESPIRATORY MEDICINE, 2010, 104 : S86 - S91
  • [29] Regenerative Medicine for the Kidney: Renotropic Factors, Renal Stem/Progenitor Cells, and Stem Cell Therapy
    Maeshima, Akito
    Nakasatomi, Masao
    Nojima, Yoshihisa
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy
    Baldwin, Kismet
    Urbinati, Fabrizia
    Romero, Zulema
    Campo-Fernandez, Beatriz
    Kaufman, Michael L.
    Cooper, Aaron R.
    Masiuk, Katelyn
    Hollis, Roger P.
    Kohn, Donald B.
    STEM CELLS, 2015, 33 (05) : 1532 - 1542
12345